BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.2.3.1//EN TZID:America/Phoenix X-WR-TIMEZONE:America/Phoenix BEGIN:VEVENT UID:1507@azbio.org DTSTART;TZID=America/Phoenix:20200914T100000 DTEND;TZID=America/Phoenix:20200914T110000 DTSTAMP:20200910T033032Z URL:https://www.azbio.org/events/the-critical-path-institute-15-years-of-i mpact SUMMARY:The Critical Path Institute: 15 Years of Impact  - - 14 Sep 20 10 :00 DESCRIPTION:\n\n \;\nThe Critical Path Institute: 15 Years of Impact&nb sp\;\nPresented Virtually Via Webex.\n\nRegister for this and other free A rizona Bioscience Week Educational Events via the AZBW2020 App\nRegister f or AZBW 2020\nProgram Description \;\n\n \;A catalyst in the devel opment of new \;tools and \;approaches to advance regulatory scien ce \;and medical product development\, Tucson-based Critical Path Inst itute has been leading teams that share data\, \;knowledge \;and e xpertise resulting in sound\, consensus-based science for more than 15 yea rs. Even through \;these unprecedented times\, C-Path \;continues& nbsp\;to forge ahead\, charting new territory and laying the groundwork fo r innovative drug development that will lead to treatments and cures for p atients around the globe. \; \;\n\n \;\n\nPresenter: \;\n\ nKlaus Romero\, MD\, MS\, FCP\, C-Path Chief Science Officer \;\n\nKla us Romero MD\, MS\, FCP is a clinical pharmacologist and epidemiologist by training\, with 15 years combined experience in academic clinical researc h. Dr. Romero has been with C-Path since December of 2007\, and during his tenure\, he has helped lead clinical pharmacology\, pharmacoepidemiology and modeling and simulation projects in Alzheimer’s disease\, polycystic kidney disease\, tuberculosis\, type 1 diabetes\, Parkinson’s disease\, Duchenne muscular dystrophy\, kidney transplantation and Huntington’s d isease\, achieving major milestones such as the first regulatory endorseme nt by FDA and EMA of a clinical trial simulation tool for mild and moderat e Alzheimer’s Disease and the qualification of an imaging prognostic bio marker for PKD. He is a fellow of the American College of Clinical Pharmac ology and the American Society for Clinical Pharmacology and Therapeutics. END:VEVENT BEGIN:VTIMEZONE TZID:America/Phoenix X-LIC-LOCATION:America/Phoenix BEGIN:STANDARD DTSTART:20190915T100000 TZOFFSETFROM:-0700 TZOFFSETTO:-0700 TZNAME:MST END:STANDARD END:VTIMEZONE END:VCALENDAR